South Pasadena, CA, United States of America

Derald E Brackmann

This inventor holds 1 USPTO granted patent. Top assignee: House Ear Institute. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Derald E. Brackmann

Introduction

Derald E. Brackmann is a notable inventor based in South Pasadena, California. He has made significant contributions to the field of otology through his innovative research and patents. His work focuses on the study of human middle ear epithelial cell lines, which has implications for understanding and treating ear diseases.

Latest Patents

Brackmann holds a patent for "Immortalized human middle ear epithelial cell lines." This patent describes human middle ear epithelial cell lines that have been permanently transformed by human papilloma viruses. These cell lines are valuable for studying gene and protein expression in otitis media, as well as for identifying chemical and biological agents that may aid in the therapy of human otitis media and other ear-related diseases. He has 1 patent to his name.

Career Highlights

Brackmann is associated with the House Ear Institute, where he conducts his research. His work has been instrumental in advancing the understanding of ear diseases and potential treatments. His dedication to research has positioned him as a key figure in the field of otology.

Collaborations

Some of his notable coworkers include David J. Lim and Young-Myoung Chun. Their collaborative efforts contribute to the ongoing research and development in the field of ear health.

Conclusion

Derald E. Brackmann's contributions to the field of otology through his innovative patents and research are commendable. His work continues to impact the understanding and treatment of ear diseases, showcasing the importance of innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…